Several pathways have been implicated in breast cancer, including p53, epidermal growth factor receptor (EGFR), PDGF/PDGFR, PI3K/AKT, and mammalian target of rapamycin (mTOR) [2]. This evidence concerns the gene PDGFRB and breast carcinoma.